Mixed options sentiment in Pfizer (PFE), with shares up 30c, or 1.15%, near $26.00. Options volume roughly in line with average with 139k contracts traded and calls leading puts for a put/call ratio of 0.38, compared to a typical level near 0.4. Implied volatility (IV30) dropped 1.07 near 22.31,in the bottom quartile of the past year, suggesting an expected daily move of $0.37. Put-call skew steepened, indicating increased demand for downside protection.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Salesforce (CRM) Wins AstraZeneca Deal, Becomes the Unified Global Platform
- FDA shift in drug study requirements sends trial runners lower
- FDA to reduce number of trials required for drug approvals, STAT reports
- Mixed options sentiment in Pfizer with shares up 2.09%
- Is AstraZeneca’s Stock (AZN) a Good Investment Right Now?